Ameriprise
IMGN

Ameriprise’s Immunogen Inc IMGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,619
Closed -$226K 4006
2023
Q4
$226K Buy
+7,619
New +$226K ﹤0.01% 3695
2023
Q3
Sell
-41,815
Closed -$789K 3990
2023
Q2
$789K Sell
41,815
-245,052
-85% -$4.62M ﹤0.01% 3272
2023
Q1
$1.1M Sell
286,867
-882
-0.3% -$3.39K ﹤0.01% 3101
2022
Q4
$1.43M Buy
287,749
+162,984
+131% +$808K ﹤0.01% 2959
2022
Q3
$596K Sell
124,765
-1,451
-1% -$6.93K ﹤0.01% 3318
2022
Q2
$568K Buy
126,216
+676
+0.5% +$3.04K ﹤0.01% 3351
2022
Q1
$598K Buy
+125,540
New +$598K ﹤0.01% 3417
2021
Q2
Sell
-5,595,683
Closed -$45.3M 3978
2021
Q1
$45.3M Buy
5,595,683
+3,738,190
+201% +$30.3M 0.02% 815
2020
Q4
$12M Buy
1,857,493
+439,857
+31% +$2.84M ﹤0.01% 1602
2020
Q3
$5.1M Sell
1,417,636
-19,513
-1% -$70.3K ﹤0.01% 2068
2020
Q2
$6.61M Buy
1,437,149
+1,412,568
+5,747% +$6.5M ﹤0.01% 1860
2020
Q1
$84K Buy
24,581
+1,619
+7% +$5.53K ﹤0.01% 3548
2019
Q4
$117K Buy
22,962
+2,214
+11% +$11.3K ﹤0.01% 3629
2019
Q3
$50K Buy
+20,748
New +$50K ﹤0.01% 3658
2018
Q3
Sell
-127,776
Closed -$1.24M 3779
2018
Q2
$1.24M Buy
127,776
+21,872
+21% +$213K ﹤0.01% 2933
2018
Q1
$1.11M Buy
+105,904
New +$1.11M ﹤0.01% 2931
2017
Q4
Sell
-208,574
Closed -$1.6M 3739
2017
Q3
$1.6M Sell
208,574
-9,819
-4% -$75.1K ﹤0.01% 2725
2017
Q2
$1.55M Sell
218,393
-176,377
-45% -$1.25M ﹤0.01% 2734
2017
Q1
$1.53M Buy
+394,770
New +$1.53M ﹤0.01% 2698
2016
Q2
Sell
-11,988
Closed -$102K 3831
2016
Q1
$102K Sell
11,988
-5,150
-30% -$43.8K ﹤0.01% 3604
2015
Q4
$233K Buy
17,138
+2,233
+15% +$30.4K ﹤0.01% 3579
2015
Q3
$143K Buy
14,905
+158
+1% +$1.52K ﹤0.01% 3662
2015
Q2
$212K Buy
14,747
+2,704
+22% +$38.9K ﹤0.01% 3772
2015
Q1
$108K Buy
+12,043
New +$108K ﹤0.01% 3675
2014
Q4
Sell
-6,415
Closed -$68K 4531
2014
Q3
$68K Buy
6,415
+4,242
+195% +$45K ﹤0.01% 3853
2014
Q2
$26K Buy
2,173
+1,675
+336% +$20K ﹤0.01% 4196
2014
Q1
$8K Sell
498
-380
-43% -$6.1K ﹤0.01% 4622
2013
Q4
$13K Sell
878
-4,894
-85% -$72.5K ﹤0.01% 4262
2013
Q3
$99K Sell
5,772
-219
-4% -$3.76K ﹤0.01% 3469
2013
Q2
$99K Buy
+5,991
New +$99K ﹤0.01% 3392